AI Discovers Peptides in Lion's Mane Mushroom That Lower Blood Pressure and Fight Oxidation

An AI-assisted workflow using DeepSeek identified 7 functional peptides in lion's mane mushroom with dual antioxidant and ACE-inhibitory activities, validated by laboratory assays.

Chen, Rongheng et al.·Food chemistry·2026·
RPEP-149912026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

AI-assisted annotation identified 7 dual-function peptides in Hericium erinaceus with confirmed antioxidant and ACE-inhibitory activities through laboratory validation.

Key Numbers

How They Did This

LLM-assisted peptide annotation (DeepSeek platform) combined with LC-MS/MS, antioxidant assays, ACE-inhibitory assays, and cellular evaluations.

Why This Research Matters

Traditional peptide discovery is slow and expensive. Using AI to predict which peptides have therapeutic properties dramatically accelerates finding natural compounds for blood pressure and oxidative stress management.

The Bigger Picture

This is one of the first studies using large language models for bioactive peptide discovery — demonstrating that AI tools originally designed for text can be repurposed for scientific discovery in food and pharmaceutical sciences.

What This Study Doesn't Tell Us

In vitro validation only — in vivo blood pressure effects not tested; peptide bioavailability and digestive stability unknown; AI predictions require experimental confirmation.

Questions This Raises

  • ?Can AI-discovered mushroom peptides actually lower blood pressure in animal models or humans?
  • ?Could this AI-assisted approach be applied systematically across all edible fungi?

Trust & Context

Key Stat:
7 AI-identified peptides DeepSeek LLM accurately predicted functional peptides validated by lab assays
Evidence Grade:
Novel AI-assisted discovery with in vitro validation — innovative methodology but lacks in vivo efficacy data.
Study Age:
Published in 2026, at the forefront of AI-assisted bioactive peptide discovery.
Original Title:
AI-assisted discovery of dual antioxidant and ACE-inhibitory peptides from Hericium erinaceus.
Published In:
Food chemistry, 506, 148179 (2026)
Database ID:
RPEP-14991

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can lion's mane mushroom lower blood pressure?

This study found peptides in lion's mane that inhibit ACE, the same enzyme targeted by blood pressure medications, and also have antioxidant effects. However, eating the mushroom or taking supplements hasn't been proven to lower blood pressure in humans yet.

How was AI used to find these peptides?

The researchers used DeepSeek, a large language model, to analyze protein sequences from the mushroom and predict which peptide fragments would have biological activity — like a smart search engine for therapeutic molecules.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14991·https://rethinkpeptides.com/research/RPEP-14991

APA

Chen, Rongheng; Yu, Jiahao; Feng, Simin; Shao, Ping. (2026). AI-assisted discovery of dual antioxidant and ACE-inhibitory peptides from Hericium erinaceus.. Food chemistry, 506, 148179. https://doi.org/10.1016/j.foodchem.2026.148179

MLA

Chen, Rongheng, et al. "AI-assisted discovery of dual antioxidant and ACE-inhibitory peptides from Hericium erinaceus.." Food chemistry, 2026. https://doi.org/10.1016/j.foodchem.2026.148179

RethinkPeptides

RethinkPeptides Research Database. "AI-assisted discovery of dual antioxidant and ACE-inhibitory..." RPEP-14991. Retrieved from https://rethinkpeptides.com/research/chen-2026-aiassisted-discovery-of-dual

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.